Literature DB >> 2536357

Preliminary evidence that Clostridium perfringens type A enterotoxin is present in a 160,000-Mr complex in mammalian membranes.

A P Wnek1, B A McClane.   

Abstract

Clostridium perfringens type A 125I-enterotoxin (125I-CPE) was bound to rabbit intestinal brush border membranes (BBMs) or Vero cells and then solubilized with 3-[(3-cholamidopropyl)dimethyl-ammonio]-1-propanesulfonate (CHAPS). Solubilized radioactivity was analyzed by gel filtration chromatography on a Sepharose 4B column or by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) without sample boiling and autoradiography. Specifically bound 125I-CPE extracted from either BBMs or Vero cells was primarily associated with a complex of approximately 160,000 Mr. The CPE complex was partially purified by gel filtration or SDS-PAGE without sample boiling. SDS-PAGE analysis with sample boiling of the partially purified 125I-CPE complex from Vero cells or BBMs suggested that CPE complex contains both a 50,000-Mr protein and a 70,000-Mr protein in approximately equimolar amounts. This result is supported by affinity chromatography with CPE immobilized on Sepharose 4B, which showed the specific interaction of similar size proteins with CPE. The simplest explanation for these results is that CPE (Mr 35,000) interacts with 50,000-Mr and 70,000-Mr eucaryotic proteins to form a membrane-dependent complex of approximately 160,000 Mr. These results suggest that the receptor or target site(s) or both for CPE are similar in both BBMs and Vero cells. The significance of these findings in terms of CPE binding, insertion, and biologic action is discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2536357      PMCID: PMC313135          DOI: 10.1128/iai.57.2.574-581.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  A hydrophobic form of the small-intestinal sucrase-isomaltase complex.

Authors:  H Sigrist; P Ronner; G Semenza
Journal:  Biochim Biophys Acta       Date:  1975-10-17

2.  The effects of Clostridium perfringens enterotoxin on morphology, viability, and macromolecular synthesis in Vero cells.

Authors:  B A McClane; J L McDonel
Journal:  J Cell Physiol       Date:  1979-05       Impact factor: 6.384

3.  Binding versus biological activity of Clostridium perfringens enterotoxin in Vero cells.

Authors:  J L McDonel; B A McClane
Journal:  Biochem Biophys Res Commun       Date:  1979-03-30       Impact factor: 3.575

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Intracellular antibody against Clostridium perfringens enterotoxin fails to counteract toxin-induced damage.

Authors:  H T Petrie; J L McDonel; R A Schlegel
Journal:  Cell Biol Int Rep       Date:  1982-07

6.  Inhibition of protein synthesis by a tryptic polypeptide of Clostridium perfringens type A enterotoxin.

Authors:  P E Granum
Journal:  Biochim Biophys Acta       Date:  1982-10-20

7.  Quantitation of binding and subcellular distribution of Clostridium perfringens enterotoxin in rat liver cells.

Authors:  H Tolleshaug; R Skjelkvåle; T Berg
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

8.  Mechanism of action of Clostridium perfringens enterotoxin. Effects on membrane permeability and amino acid transport in primary cultures of adult rat hepatocytes.

Authors:  O Giger; M W Pariza
Journal:  Biochim Biophys Acta       Date:  1980-01-25

9.  Binding of Clostridium perfringens [125I]enterotoxin to rabbit intestinal cells.

Authors:  J L McDonel
Journal:  Biochemistry       Date:  1980-10-14       Impact factor: 3.162

10.  Anomalous aggregation of Clostridium perfringens enterotoxin under dissociating conditions.

Authors:  G L Enders; C L Duncan
Journal:  Can J Microbiol       Date:  1976-09       Impact factor: 2.419

View more
  17 in total

1.  Mapping of functional regions of Clostridium perfringens type A enterotoxin.

Authors:  P C Hanna; E U Wieckowski; T A Mietzner; B A McClane
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

2.  A conjugated synthetic peptide corresponding to the C-terminal region of Clostridium perfringens type A enterotoxin elicits an enterotoxin-neutralizing antibody response in mice.

Authors:  T A Mietzner; J F Kokai-Kun; P C Hanna; B A McClane
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

3.  Noncytotoxic Clostridium perfringens enterotoxin (CPE) variants localize CPE intestinal binding and demonstrate a relationship between CPE-induced cytotoxicity and enterotoxicity.

Authors:  James G Smedley; Juliann Saputo; Jacquelyn C Parker; Mariano E Fernandez-Miyakawa; Susan L Robertson; Bruce A McClane; Francisco A Uzal
Journal:  Infect Immun       Date:  2008-05-27       Impact factor: 3.441

Review 4.  Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion.

Authors:  C L Sears; J B Kaper
Journal:  Microbiol Rev       Date:  1996-03

5.  Deletion analysis of the Clostridium perfringens enterotoxin.

Authors:  J F Kokai-Kun; B A McClane
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

6.  Correlation between plasmid content and infectivity in Borrelia burgdorferi.

Authors:  J E Purser; S J Norris
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

7.  Molecular cloning of the 3' half of the Clostridium perfringens enterotoxin gene and demonstration that this region encodes receptor-binding activity.

Authors:  P C Hanna; A P Wnek; B A McClane
Journal:  J Bacteriol       Date:  1989-12       Impact factor: 3.490

8.  Expression from the Clostridium perfringens cpe promoter in C. perfringens and Bacillus subtilis.

Authors:  S B Melville; R Labbe; A L Sonenshein
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

9.  Characterization of membrane-associated Clostridium perfringens enterotoxin following pronase treatment.

Authors:  E U Wieckowski; J F Kokai-Kun; B A McClane
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

10.  Evidence that a region(s) of the Clostridium perfringens enterotoxin molecule remains exposed on the external surface of the mammalian plasma membrane when the toxin is sequestered in small or large complexes.

Authors:  J F Kokai-Kun; B A McClane
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.